Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 50.5 EUR 0.2% Market Closed
Market Cap: 10.4B EUR
Have any thoughts about
Recordati Industria Chimica e Farmaceutica SpA?
Write Note

Relative Value

The Relative Value of one REC stock under the Base Case scenario is 63.14 EUR. Compared to the current market price of 50.5 EUR, Recordati Industria Chimica e Farmaceutica SpA is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

REC Relative Value
Base Case
63.14 EUR
Undervaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
26
Median 3Y
4.7
Median 5Y
4.9
Industry
2.5
Forward
4.4
vs History
52
vs Industry
17
Median 3Y
25.4
Median 5Y
24.8
Industry
21.8
Forward
21.3
vs History
60
vs Industry
21
Median 3Y
18.6
Median 5Y
20.5
Industry
16.1
vs History
9
vs Industry
12
Median 3Y
31.8
Median 5Y
35.5
Industry
23.8
vs History
68
vs Industry
12
Median 3Y
5.8
Median 5Y
6
Industry
2.1
vs History
76
vs Industry
22
Median 3Y
5.3
Median 5Y
5.4
Industry
2.7
Forward
4.9
vs History
71
vs Industry
26
Median 3Y
7.7
Median 5Y
7.9
Industry
5.2
vs History
80
vs Industry
22
Median 3Y
15.1
Median 5Y
15.1
Industry
13.5
Forward
13.4
vs History
71
vs Industry
21
Median 3Y
18.8
Median 5Y
18.9
Industry
16.8
Forward
17
vs History
57
vs Industry
21
Median 3Y
20.9
Median 5Y
22.2
Industry
15.2
vs History
57
vs Industry
6
Median 3Y
25
Median 5Y
24.8
Industry
19.3
vs History
61
vs Industry
26
Median 3Y
3
Median 5Y
3.2
Industry
1.9

Multiples Across Competitors

REC Competitors Multiples
Recordati Industria Chimica e Farmaceutica SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
10.4B EUR 4.6 24.6 14.6 18.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.6B GBP 4.1 31.4 169.3 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Average P/E: 31.5
24.6
57%
0.4
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Average EV/EBITDA: 415.1
14.6
44%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.3
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Average EV/EBIT: 1 812
18.2
49%
0.4
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top